Ilpio (Indapamide, Telmisartan)

Indapamide / Telmisartan, the active ingredient in Ilpio, is a thiazide‑like diuretic and angiotensin II receptor blocker combination presented as an oral tablet for oral use. It is prescribed to lower elevated blood pressure in adult patients with hypertension.

GNH USA supplies Ilpio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution, offering reliable batch consistency and responsive technical support.

Ilpio is indicated for the management of hypertension, a condition characterized by chronically elevated arterial pressure.

- Essential hypertension: helps achieve target blood pressure levels and reduces cardiovascular risk. - Stage 1 hypertension: provides additional blood pressure lowering when monotherapy is insufficient. - Stage 2 hypertension: used in combination therapy to attain adequate control in more severe cases.

Like all antihypertensive agents, Ilpio may be associated with adverse reactions that vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness, especially after the first dose. - Headache. - Fatigue or mild weakness. - Increased urination.

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hyponatremia, hypokalemia). - Acute kidney injury or significant rise in serum creatinine. - Angio‑edema involving the face, lips, or airway.

Prior to initiating Ilpio, clinicians should evaluate several safety considerations to minimize risk.

- Renal function: assess creatinine clearance and adjust therapy if severe impairment is present. - Electrolytes: monitor serum potassium and sodium levels, particularly in patients on other diuretics. - Hepatic disease: use with caution in patients with liver impairment. - Concomitant antihypertensives: avoid excessive blood pressure lowering when combined with other agents. - Store at ambient temperature below 25 °C: keep in the original container, protect from moisture and direct sunlight.

Ilpio can interact with other medicines, altering its antihypertensive effect or increasing the risk of adverse events.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: may cause hyperkalaemia. - Strong CYP2C9 inhibitors (e.g., fluconazole): can increase telmisartan plasma concentrations.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce diuretic efficacy and impair renal function. - Lithium: concurrent use can raise lithium levels, risking toxicity.